Senetas Corporation (SEN) Fair Value & Analysis
Technology · AU · Market cap A$51.4M
Fair value as of: Jun 25, 2026
Analysis
Senetas Corporation (SEN) currently trades at A$2.80, while our model-based Fair Value estimate is A$4.03 — implying the stock looks roughly 43.9% undervalued today. We read business quality at 84/100 (high quality), in the Technology sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.
About the company
Senetas Corporation Limited, together with its subsidiaries, engages in the development, manufacture, and sale of information technology products which provide network data security solutions to businesses and governments worldwide. It develops and manufactures encryption hardware; virtualized network encryption software; and advanced encrypted file sharing application. The company's products include CypherNET CN series network encryptors and CV series virtualized network encryption solution, SureDrop secure file sharing and collaboration solution; and CM7 network encryption management platform, as well as offers support and maintenance services. It serves commercial cyber security, government and defense, infrastructure, finance, gaming, and healthcare industries. The company was incorporated in 1982 and is based in Melbourne, Australia.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is Senetas Corporation (SEN) undervalued?
What is the fair value of SEN?
What is the quality score of SEN?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.